S-OA-H
Oral Abstracts - Session H - Pediatric Disorders
BMT Tandem "Scientific" Meeting
Texas C (Gaylord Texan)
Chairs:
Leslie S. Kean, MD, PhD
and
Kirsten M. Williams, MD
Disclosures:
L. S. Kean,
Nothing To Disclose
K. M. Williams,
Nothing To Disclose
Pre-Hematopoietic Cell Transplant (HCT) Disease Status and Early Post-HCT Bone Marrow (BM) Chimerism Remain Predictors of Leukemia Relapse in Children Who Receive Preemptive Post-HCT Immunomodulatory Therapy (IT)
Biljana Horn, MD, UCSF Benioff Children's Hospital;
Aleksandra Petrovic, MD, All Children's Hospital;
Justin T Wahlstrom, M.D., UCSF Benioff Children's Hospital;
Christopher C. Dvorak, MD, University of California San Francisco Medical Center;
Denice Kong, UCSF;
Jueleah Exposer-Spencer, Benioff Children's Hospital at UCSF;
Morton J Cowan, MD, UCSF Benioff Children's Hospital
Durable Engraftment, Correction of Genetic Defects and Prevention of Veno-Occlussive Disease, Following Blood and Marrow Transplantation with an HLA-Matched Sibling DONOR, Using a Reduced Toxicity Conditioning Regimen with Busulfan, Reduced Dose Cyclophos
Kris Michael Mahadeo, MD, MPH, Children's Hospital Los Angeles;
Rajni Agarwal, MD, Stanford University;
Kenneth I Weinberg, MD, Pediatric Stem Cell Transplantation, Stanford University;
Hisham Abdel-Azim, MD, Children's Hospital Los Angeles;
David B. Miklos, MD, PhD, Stanford University School of Medicine;
Ami J Shah, MD, Children's Hospital Los Angeles;
Laraib Tabba, MD, Children's Hospital Los Angeles;
Neena Kapoor, MD, Children's Hospital Los Angeles
Intrathecal Chemotherapy Post Hematopoietic Cell Transplantation for Prevention of Central Nervous System Relapse in Pediatric Acute Leukemia
Richard Mitchell, MBBS, Memorial Sloan-Kettering Cancer Center;
Niketa Shah, MD, Phoenix Children's Hospital;
Rachel Lehrman, BS, Memorial Sloan-Kettering Cancer Center;
Rachel Kobos, MD, Memorial Sloan-Kettering Cancer Center;
Andromachi Scaradavou, MD, New York Blood Center;
Farid Boulad, MD, Memorial Sloan-Kettering Cancer Center;
Nancy Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Richard O'Reilly, MD, Memorial Sloan-Kettering Cancer Center;
Susan E. Prockop, MD, Memorial Sloan-Kettering Cancer Center
Incidence of and Risk Factors for Cytomegalovirus (CMV), Epstein Barr Virus (EBV) and Adenovirus (ADV) Reactivation in Pediatric Recipients Post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHCT)
Evelyn Rustia, New York Presbyterian Morgan Stanley Children’s Hospital;
Leah Violago, Children's Hospital of New York Presbyterian;
Zhezhen Jin, PhD, Columbia University;
Monica Bhatia, MD, Columbia University;
Andrew Kung, MD, PhD, Columbia University;
Marc Foca, Columbia University;
Diane George, MD, Columbia University;
James Garvin, MD, PhD, Columbia University;
Prakash Satwani, MD, Columbia University
Sequential Myeloablative Autologous Stem Cell Transplantation and Reduced Intensity Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor Risk Refractory or Recurrent Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL)
Prakash Satwani, MD, Columbia University;
Zhezhen Jin, PhD, Columbia University;
Monica Bhatia, MD, Columbia University;
James Garvin, MD, PhD, Columbia University;
Diane George, MD, Columbia University;
Sonali Chaudhury, Ann & Robert H. Lurie Children's Hospital of Chicago;
Julie-An Talano, MD, Children's Hospital of Wisconsin;
Jean Sosna, CRN, Columbia University;
Erin Morris, RN, BSN, New York Medical College;
Lauren Harrison, RN, New York Medical College;
Paul L. Martin, MD, PhD, Duke University Medical Center;
Margaret Peterson, CRN, Duke University;
Joanne Kurtzberg, MD, Duke University Medical Center;
Mitchell S. Cairo, MD, New York Medical College
